retatrutide mechanism triple agonist gip glp-1 glucagon retatrutide Dosage & Titration: Complete Escalation Protocol (5-30 mg) Retatrutide 40mg Pen | Triple

Clinical trials show retatrutide results in significant weight loss (up to 24.2%) and improved glycemic control, making it a beneficial treatment for obesity and diabetes

What happens if I stop taking it

Individuals should embrace a holistic approach, considering factors such as mental health, long-term lifestyle changes, and a supportive healthcare team

Those looking for extreme or immediate results may not find it suitable, but individuals seeking a gentler, long-term approach often view it as a strong fit

Liraglutide 3.0 mgs efficacy in obesity was assessed in the Satiety and Clinical Adiposity-Liraglutide (SCALE) Obesity and Prediabetes and SCALE-diabetes trials [15,41]

1,3 A 2025 systematic review in the International Journal of Dermatology confirmed that among GLP-1 receptor agonists, semaglutide and tirzepatide showed the highest reported incidence of hair loss, with telogen effluvium and androgenetic alopecia (AGA) identified as the predominant subtypes